MGTX
Price
$6.26
Change
+$0.33 (+5.56%)
Updated
Jan 17 closing price
Capitalization
489.24M
53 days until earnings call
MTVA
Price
$1.95
Change
+$0.06 (+3.17%)
Updated
Jan 17 closing price
Capitalization
16.76M
Ad is loading...

MGTX vs MTVA

Header iconMGTX vs MTVA Comparison
Open Charts MGTX vs MTVABanner chart's image
MeiraGTx Holdings
Price$6.26
Change+$0.33 (+5.56%)
Volume$445.64K
Capitalization489.24M
MetaVia
Price$1.95
Change+$0.06 (+3.17%)
Volume$31.58K
Capitalization16.76M
MGTX vs MTVA Comparison Chart
Loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MGTX vs. MTVA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTX is a Hold and MTVA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MGTX: $6.26 vs. MTVA: $1.95)
Brand notoriety: MGTX and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MGTX: 159% vs. MTVA: 17%
Market capitalization -- MGTX: $489.24M vs. MTVA: $16.76M
MGTX [@Biotechnology] is valued at $489.24M. MTVA’s [@Biotechnology] market capitalization is $16.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MGTX’s FA Score shows that 0 FA rating(s) are green whileMTVA’s FA Score has 1 green FA rating(s).

  • MGTX’s FA Score: 0 green, 5 red.
  • MTVA’s FA Score: 1 green, 4 red.
According to our system of comparison, MTVA is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MGTX’s TA Score shows that 4 TA indicator(s) are bullish while MTVA’s TA Score has 4 bullish TA indicator(s).

  • MGTX’s TA Score: 4 bullish, 3 bearish.
  • MTVA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than MTVA.

Price Growth

MGTX (@Biotechnology) experienced а +0.97% price change this week, while MTVA (@Biotechnology) price change was -5.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

MGTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($489M) has a higher market cap than MTVA($16.8M). MGTX YTD gains are higher at: 2.791 vs. MTVA (-4.187). MTVA has higher annual earnings (EBITDA): -25.46M vs. MGTX (-61.2M). MGTX has more cash in the bank: 123M vs. MTVA (21.7M). MTVA has less debt than MGTX: MTVA (154K) vs MGTX (86.7M). MGTX has higher revenues than MTVA: MGTX (13.9M) vs MTVA (0).
MGTXMTVAMGTX / MTVA
Capitalization489M16.8M2,911%
EBITDA-61.2M-25.46M240%
Gain YTD2.791-4.187-67%
P/E RatioN/AN/A-
Revenue13.9M0-
Total Cash123M21.7M567%
Total Debt86.7M154K56,299%
FUNDAMENTALS RATINGS
MGTX vs MTVA: Fundamental Ratings
MGTX
MTVA
OUTLOOK RATING
1..100
7554
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5193
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTVA's Valuation (24) in the null industry is somewhat better than the same rating for MGTX (57) in the Biotechnology industry. This means that MTVA’s stock grew somewhat faster than MGTX’s over the last 12 months.

MTVA's Profit vs Risk Rating (100) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's SMR Rating (98) in the Biotechnology industry is in the same range as MTVA (99) in the null industry. This means that MGTX’s stock grew similarly to MTVA’s over the last 12 months.

MGTX's Price Growth Rating (51) in the Biotechnology industry is somewhat better than the same rating for MTVA (93) in the null industry. This means that MGTX’s stock grew somewhat faster than MTVA’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as MTVA (100) in the null industry. This means that MGTX’s stock grew similarly to MTVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MGTXMTVA
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
74%
MACD
ODDS (%)
Bullish Trend 11 days ago
76%
Bullish Trend 11 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
79%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
81%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 11 days ago
86%
View a ticker or compare two or three
Ad is loading...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEQMX38.460.40
+1.05%
Fidelity Advisor Emerging Markets M
HCMGX29.640.23
+0.78%
HCM Tactical Growth A
JGEMX11.920.07
+0.59%
JHancock Global Equity R6
WSMVX26.830.14
+0.52%
Wilshire Small Company Value Instl
LAFAX25.470.13
+0.51%
Columbia Acorn International Sel A

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+5.56%
BEAM - MGTX
54%
Loosely correlated
+0.17%
NTLA - MGTX
54%
Loosely correlated
+0.85%
CRSP - MGTX
51%
Loosely correlated
+0.57%
AURA - MGTX
50%
Loosely correlated
+1.30%
PRME - MGTX
50%
Loosely correlated
+0.70%
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with MGTX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+2.91%
MGTX - MTVA
45%
Loosely correlated
+5.56%
HOOK - MTVA
44%
Loosely correlated
+0.52%
PMVP - MTVA
35%
Loosely correlated
N/A
KPRX - MTVA
31%
Poorly correlated
+11.71%
ANNX - MTVA
28%
Poorly correlated
+2.19%
More